辅助剂对超和,粒子大小动态和多药无形配方的热力学活性的影响
Mira El Sayed1, Amjad Alhalaweh2, Lucia Kovac3
1Department of Pharmacy, Uppsala University, Biomedical Centre, P.O. Box 580, SE-751 23 Uppsala, Sweden; Recipharm OT Chemistry AB, SE-754 50 Uppsala, Sweden.
International journal of pharmaceutics
|September 22, 2024
概括
选择正确的辅助剂对于无形药物配方至关重要. 辅助剂显著影响药物的溶解性,超和吸收,影响整体生物可用性.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 物理化学 物理化学
背景情况:
- 多种药物配方可以改善患者的服药规范和产品的生命周期.
- 无形配方解决了药物组合中的溶解性挑战.
- 无形配方的辅助剂选择往往缺乏对其生物可用性影响的清晰理解.
研究的目的:
- 研究聚合物,表面活性剂和氨基酸对无形药物配方的影响.
- 评估辅助剂对药物超和和热力学活性的影响.
- 分析液-液相分离的体系统中的粒子大小动态.
主要方法:
- 在辅助剂溶液中确定阿扎纳维尔和利托纳维尔的无形溶解度.
- 使用动态光散射测量了体颗粒大小动态.
- 进行了溶解和膜传输研究 (MicroFLUX).
主要成果:
- 聚合物对无形溶解度的影响最小,但保持了超和,并防止了颗粒粗.
- 二甲基硫酸盐 (SDS) 显著增加了药物溶解度,但减少了药物流量.
- 氨基酸和非离子表面活性剂具有多种作用,氨酸未能抑制结晶或增加药物流量.
结论:
- 适当的辅助剂选择对于优化超和无形配方至关重要.
- 助剂影响药物的热力学活性和相位行为,影响口服吸收.
- 这项研究强调了辅助剂查的必要性,以确保所需的药物生物可用性.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
289
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
289
Factors Influencing Drug Absorption: Pharmaceutical Parameters
123
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
123
Factors Affecting Dissolution: Particle Size and Effective Surface Area
757
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
757
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
179
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
179
Factors Influencing Drug Absorption: Physicochemical Parameters
238
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
238
Factors Influencing Drug Absorption: Drug Dissolution
425
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
425


